| Date | Form | Description | Docs | XBRL | Pages |
| 06/14/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 | |
| 03/31/99 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 03/16/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 | |
| 01/29/99 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
42 | |
| 09/14/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/29/98 | DEF 14A | Definitive proxy statements |
|
9 | |
| 06/15/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 03/17/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 01/29/98 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
40 | |
| 09/12/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
17 |
Latest News & Events
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences Clarifies Poster Presentation on Company Website
Read More...Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Read More...